Publication
Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2(nd) -line therapy for relapsed and refractory multiple myeloma - a phase II trial
Journal Paper/Review - Dec 16, 2016
Mey Ulrich J M, Ruefer Axel, Ziske Carsten, Knauf Wolfgang, Cathomas Richard, von Moos Roger, Hitz Felicitas, Sauter Rafael, Hiendlmeyer Elke, Cantoni Nathan, Bargetzi Mario, Fischer Natalie, Doerfel Steffen, Brugger Wolfram, Schwarb Heike, Pederiva Stefanie, Schwarzer Andreas, Dechow Tobias, Jehner Paul, Rauh Jacqueline, Taverna Christian J, Schmid Mathias, Schmidt-Hieber Martin, Driessen Christoph
Mey, Ulrich J M
6
0
Brugger, Wolfram
3
0
Schwarb, Heike
1
0
Pederiva, Stefanie
2
0
Schwarzer, Andreas
1
0
Dechow, Tobias
2
0
Jehner, Paul
1
0
Rauh, Jacqueline
1
0
Taverna, Christian J
1
0
Schmid, Mathias
2
0
Schmidt-Hieber, Martin
1
0
Doerfel, Steffen
1
0
Fischer, Natalie
8
0
Ruefer, Axel
2
0
Ziske, Carsten
1
0
Knauf, Wolfgang
1
0
Cathomas, Richard
55
1
von Moos, Roger
58
1
Hitz, Felicitas
chief of serviceMedizinische Onkologie und Hämatologie · Dept. I
52
33
Sauter, Rafael
19
2